Sort
23,748 grants matching “melanoma”
ERK Signaling in Inflammatory Bone Loss
$357,978Francis Young-In Lee · Columbia University Health Sciences · R01 · FY2010 · AR
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
$357,915Jose Alejandro Guevara-Patino · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Characterizing oncogenic function of ITCH in melanoma
$357,913Lixin Wan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Core C: Survey Shared Resource Core
$357,871Jessica Chubak · Kaiser Foundation Research Institute · P01 · FY2020 · CA
Using Clonal and Non-Clonal UV Signature Mutations to Predict Skin Cancer Risk
$357,871Douglas E Brash · Yale University · R01 · FY2023 · CA
Role of the SWI/SNF complex in tumor suppression
$357,826Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Targeting TIGIT and PD-1 in Melanoma
$357,804Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
IN VITRO/IN VIVO ACTIVATED DENDRITIC CELLS FOR MELANOMA
$357,719University Of Southern California · R01 · FY2003 · CA
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$357,712Yuhang Zhang · University Of Cincinnati · R01 · FY2022 · CA
Developing therapeutic strategies for ERK-dependent tumors
$357,666Neal Rosen · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Project 2: Mechanochemical Mechanisms and Vulnerabilities of Individual and Collective Organ-Preferential Metastasis In Vivo
$357,662Peter Friedl · Massachusetts Institute Of Technology · U54 · FY2024 · CA
Training Program in Cancer Immunobiology
$357,553Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2006 · CA
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
$357,512Janice S Blum · Indiana University Indianapolis · R01 · FY2014 · AI
Impact of Endogenous DOPA Signaling on Melanocyte Homeostasis and Melanoma Susceptibility
$357,500Todd W Ridky · University Of Pennsylvania · R56 · FY2021 · AR
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$357,393John Tanner Wilson · Vanderbilt University · R01 · FY2023 · CA
Biogenesis of Melanosomes
$357,263Seth J. Orlow · New York University School Of Medicine · R01 · FY2008 · AR
Lymph Node Alterations in Cancer
$357,254M Alanna Ruddell · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Defining critical aspects of environmental ultraviolet exposure in melanogenesis
$357,247Myles G Cockburn · University Of Southern California · R01 · FY2011 · ES
Defining critical aspects of environmental ultraviolet exposure in melanogenesis
$357,247Myles G Cockburn · University Of Southern California · R01 · FY2012 · ES
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
$357,238Edmund K. Moon · University Of Pennsylvania · R01 · FY2019 · CA
Project 3: The Evolving Role of Regional Lymph Nodes in Melanoma Progression
$357,230Amanda W. Lund · New York University School Of Medicine · U54 · FY2024 · CA
Transcriptional mechanisms and melanoma
$357,175Leonard I Zon · Massachusetts General Hospital · P01 · FY2022 · CA
Transcriptional mechanisms and melanoma
$357,170Leonard I Zon · Massachusetts General Hospital · P01 · FY2023 · CA
Tumor Neovasculature Vector Targeting
$357,167Sidney Kimmel Cancer Center · R21 · FY2002 · CA
Combining senescence-inducing and senolytic agents to improve melanoma therapy
$357,067Anna E Vilgelm · Ohio State University · R37 · FY2020 · CA